Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
about
Original Antigenic Sin Response to RNA Viruses and Antiviral ImmunityVaccination in HIV-infected adults.Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells.Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection.Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected PersonsRandomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infectionSafety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccineInfluenza vaccines: unmet needs and recent developments.The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy.Booster and higher antigen doses of inactivated influenza vaccine in HIV-infected patients.Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.Fluzone® High-Dose Influenza Vaccine.Vaccination of HIV-infected pregnant women: implications for protection of their young infants.Caring for Older Adults with the Human Immunodeficiency Virus.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Timing Matters - Influenza Vaccination to HIV-Infected PatientsImmunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.Community-Acquired Pneumonia in HIV-Infected Individuals.
P2860
Q28066918-4FDCADC4-4D12-448D-9213-B1B53FCD9EADQ33980764-C45C1933-EBCB-4072-8D48-273DAE94E27FQ34229707-26E12601-2CF8-435F-9F8E-EF9EC6BBFE49Q34511678-F6653B13-E286-4B57-B5EF-E39B26F762E7Q35887739-1D11BEA5-E4E6-477A-BEEB-D5CE8DFC9393Q36241275-79502C31-60D2-405E-B733-84E9C58E9B7BQ36447589-D5B03E5D-0C29-45EF-BEAC-5B97A6147D92Q36984193-ABFF2C2F-66C4-4FEE-A51C-EB6E39E8BA72Q37309289-48ED9C25-15C6-4CB6-A984-FF0B8F7C5174Q37518273-A60E6443-871D-483F-BE51-06F88613545EQ37597821-2D69EE27-D9E9-43A1-9CE5-1A383B3FD97BQ37718861-DAB62E7C-C455-4723-A5B9-96AA933D7445Q38164661-0704A072-EDBC-4E90-87D1-7FF766EF40C4Q38611038-46B3252A-E2AC-44D0-B7A6-E1C1CAD229C9Q38639401-8244B809-E20B-4C51-826E-CB12AD09B498Q38998621-67A5267F-DC50-4F15-B114-19B5DC8F7A20Q40051928-E8AD22EF-AA38-4AFD-B551-09CDB28354A8Q40523854-4586A2F1-6320-469E-B2F9-DFD0A7B5F7B4Q40560650-60766273-1E06-41F8-9FF3-EBA18B8C20BAQ40818149-367BB8BC-9C5B-4ECC-8073-57F5BCED56AAQ41056130-40DCC466-FDA3-40CE-8F6D-1BE533D07D87Q41244491-6137684B-E282-4BA5-A530-4A77C06978C9Q42235608-1A7764A3-1291-44D6-9252-C3C14EEDC310
P2860
Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Improved immunogenicity with h ...... r, parallel, randomized trial.
@en
Improved immunogenicity with h ...... r, parallel, randomized trial.
@nl
type
label
Improved immunogenicity with h ...... r, parallel, randomized trial.
@en
Improved immunogenicity with h ...... r, parallel, randomized trial.
@nl
prefLabel
Improved immunogenicity with h ...... r, parallel, randomized trial.
@en
Improved immunogenicity with h ...... r, parallel, randomized trial.
@nl
P2093
P1476
Improved immunogenicity with h ...... er, parallel, randomized trial
@en
P2093
C Jo White
Carol DiGiorgio
Deborah Kim
Jean Boyer
Jeffrey M Jacobson
Pablo Tebas
Rosemarie Kappes
Thomas Kenney
P356
10.7326/0003-4819-158-1-201301010-00005
P407
P577
2013-01-01T00:00:00Z